Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Money talks-Philanthropists can foster gender and racial equity.

Mizrahi R.

EBioMedicine. 2019 Oct 30. pii: S2352-3964(19)30717-0. doi: 10.1016/j.ebiom.2019.10.047. [Epub ahead of print] No abstract available.

2.

Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance.

Brugger SP, Angelescu I, Abi-Dargham A, Mizrahi R, Shahrezaei V, Howes OD.

Biol Psychiatry. 2019 Jul 25. pii: S0006-3223(19)31541-0. doi: 10.1016/j.biopsych.2019.07.008. [Epub ahead of print]

PMID:
31561858
3.

Preferential Identification of Agonistic OX40 Antibodies by Using Cell Lysate to Pan Natively Paired, Humanized Mouse-Derived Yeast Surface Display Libraries.

Medina-Cucurella AV, Mizrahi RA, Asensio MA, Edgar RC, Leong J, Leong R, Lim YW, Nelson A, Niedecken AR, Simons JF, Spindler MJ, Stadtmiller K, Wayham N, Adler AS, Johnson DS.

Antibodies (Basel). 2019 Feb 19;8(1). pii: E17. doi: 10.3390/antib8010017.

4.

In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.

Da Silva T, Hafizi S, Watts JJ, Weickert CS, Meyer JH, Houle S, Rusjan P, Mizrahi R.

JAMA Psychiatry. 2019 Sep 18. doi: 10.1001/jamapsychiatry.2019.2516. [Epub ahead of print] Erratum in: JAMA Psychiatry. 2019 Oct 16;:.

PMID:
31532458
5.

Validating mitochondrial electron transport chain content in individuals at clinical high risk for psychosis.

Wu A, Da Silva T, Jacobson M, Tagore A, Lalang N, Kiang M, Mizrahi R, Andreazza AC.

Sci Rep. 2019 Sep 3;9(1):12695. doi: 10.1038/s41598-019-49180-3.

6.

Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice.

Tognin S, van Hell HH, Merritt K, Winter-van Rossum I, Bossong MG, Kempton MJ, Modinos G, Fusar-Poli P, Mechelli A, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango Lopez C, Kircher T, Nelson B, Galderisi S, Bressan R, Kwon JS, Weiser M, Mizrahi R, Sachs G, Maatz A, Kahn R, McGuire P; PSYSCAN Consortium .

Schizophr Bull. 2019 Aug 19. pii: sbz067. doi: 10.1093/schbul/sbz067. [Epub ahead of print]

PMID:
31424555
7.

Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis.

Schifani C, Pruessner J, Tseng HH, Rao N, Tagore A, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Addict Biol. 2019 Aug 6:e12812. doi: 10.1111/adb.12812. [Epub ahead of print]

PMID:
31389139
8.

Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [11C]FLB457 positron emission tomography study.

Tagore A, Schifani C, Rao N, Tseng HH, Zakzanis KK, Rusjan PM, Houle S, Mizrahi R.

Eur Neuropsychopharmacol. 2019 Sep;29(9):1023-1032. doi: 10.1016/j.euroneuro.2019.06.004. Epub 2019 Jul 24.

PMID:
31351843
9.

Negative symptoms in the clinical high-risk state for psychosis: Connection with cognition and primacy in impacting functioning.

Gerritsen C, Maheandiran M, Lepock J, Ahmed S, Kiang M, Bagby RM, Mizrahi R.

Early Interv Psychiatry. 2019 Jul 2. doi: 10.1111/eip.12843. [Epub ahead of print]

PMID:
31264790
10.

Stress precedes negative symptom exacerbations in clinical high risk and early psychosis: A time-lagged experience sampling study.

Gerritsen C, Bagby RM, Sanches M, Kiang M, Maheandiran M, Prce I, Mizrahi R.

Schizophr Res. 2019 Aug;210:52-58. doi: 10.1016/j.schres.2019.06.015. Epub 2019 Jun 24.

PMID:
31248749
11.

Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Tong J, Williams B, Rusjan PM, Mizrahi R, Lacapère JJ, McCluskey T, Furukawa Y, Guttman M, Ang LC, Boileau I, Meyer JH, Kish SJ.

J Cereb Blood Flow Metab. 2019 Jun 20:271678X19858003. doi: 10.1177/0271678X19858003. [Epub ahead of print]

PMID:
31220997
12.

Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics.

Asensio MA, Lim YW, Wayham N, Stadtmiller K, Edgar RC, Leong J, Leong R, Mizrahi RA, Adams MS, Simons JF, Spindler MJ, Johnson DS, Adler AS.

MAbs. 2019 Jul;11(5):870-883. doi: 10.1080/19420862.2019.1583995. Epub 2019 Mar 21.

13.

Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.

Moriguchi S, Wilson AA, Miler L, Rusjan PM, Vasdev N, Kish SJ, Rajkowska G, Wang J, Bagby M, Mizrahi R, Varughese B, Houle S, Meyer JH.

JAMA Psychiatry. 2019 Jun 1;76(6):634-641. doi: 10.1001/jamapsychiatry.2019.0044. Erratum in: JAMA Psychiatry. 2019 Apr 10;:.

PMID:
30840042
14.

Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosis.

Lepock JR, Ahmed S, Mizrahi R, Gerritsen CJ, Maheandiran M, Drvaric L, Bagby RM, Korostil M, Light GA, Kiang M.

Schizophr Res. 2019 Jan 22. pii: S0920-9964(19)30014-3. doi: 10.1016/j.schres.2019.01.014. [Epub ahead of print]

PMID:
30683525
15.

A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.

Jacobson MR, Watts JJ, Boileau I, Tong J, Mizrahi R.

Eur Neuropsychopharmacol. 2019 Mar;29(3):330-348. doi: 10.1016/j.euroneuro.2018.12.014. Epub 2019 Jan 8. Review.

PMID:
30635160
16.

Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.

Schifani C, Hafizi S, Tseng HH, Gerritsen C, Kenk M, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Schizophr Res. 2019 Nov;213:80-86. doi: 10.1016/j.schres.2018.10.008. Epub 2018 Nov 6.

PMID:
30409695
17.

GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.

Da Silva T, Hafizi S, Rusjan PM, Houle S, Wilson AA, Prce I, Sailasuta N, Mizrahi R.

J Psychiatry Neurosci. 2019 Mar 1;44(2):111-119. doi: 10.1503/jpn.170201.

18.

N400 event-related brain potential evidence for semantic priming deficits in persons at clinical high risk for psychosis.

Lepock JR, Mizrahi R, Korostil M, Maheandiran M, Gerritsen CJ, Drvaric L, Ahmed S, Bagby RM, Kiang M.

Schizophr Res. 2019 Feb;204:434-436. doi: 10.1016/j.schres.2018.08.033. Epub 2018 Sep 5. No abstract available.

PMID:
30193760
19.

Maladaptive personality traits in patients identified at lower-risk and higher-risk for psychosis.

Drvaric L, Bagby RM, Kiang M, Mizrahi R.

Psychiatry Res. 2018 Oct;268:348-353. doi: 10.1016/j.psychres.2018.08.004. Epub 2018 Aug 2.

PMID:
30098542
20.

Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.

Shakory S, Watts JJ, Hafizi S, Da Silva T, Khan S, Kiang M, Bagby RM, Chavez S, Mizrahi R.

Neuropsychopharmacology. 2018 Oct;43(11):2249-2255. doi: 10.1038/s41386-018-0163-0. Epub 2018 Jul 28.

21.

Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine.

Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ.

Drug Alcohol Depend. 2018 Sep 1;190:20-28. doi: 10.1016/j.drugalcdep.2018.05.021. Epub 2018 Jun 23.

22.

TSPO expression and brain structure in the psychosis spectrum.

Hafizi S, Guma E, Koppel A, Da Silva T, Kiang M, Houle S, Wilson AA, Rusjan PM, Chakravarty MM, Mizrahi R.

Brain Behav Immun. 2018 Nov;74:79-85. doi: 10.1016/j.bbi.2018.06.009. Epub 2018 Jun 12.

23.

Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.

Rao N, Northoff G, Tagore A, Rusjan P, Kenk M, Wilson A, Houle S, Strafella A, Remington G, Mizrahi R.

Schizophr Bull. 2019 Apr 25;45(3):670-679. doi: 10.1093/schbul/sby076.

PMID:
29878197
24.

Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.

Schifani C, Tseng HH, Kenk M, Tagore A, Kiang M, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Brain. 2018 Jul 1;141(7):2213-2224. doi: 10.1093/brain/awy133.

25.

Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.

Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G, Prce I, Wilson AA, Rusjan PM, Sailasuta N, Mizrahi R.

Neuropsychopharmacology. 2018 Jul;43(8):1700-1705. doi: 10.1038/s41386-018-0061-5. Epub 2018 Apr 13.

26.

Mitochondrial function in individuals at clinical high risk for psychosis.

Da Silva T, Wu A, Laksono I, Prce I, Maheandiran M, Kiang M, Andreazza AC, Mizrahi R.

Sci Rep. 2018 Apr 18;8(1):6216. doi: 10.1038/s41598-018-24355-6.

27.

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S.

Biol Psychiatry. 2018 Sep 15;84(6):433-442. doi: 10.1016/j.biopsych.2018.02.1171. Epub 2018 Mar 6.

28.

Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.

Da Silva T, Hafizi S, Andreazza AC, Kiang M, Bagby RM, Navas E, Laksono I, Truong P, Gerritsen C, Prce I, Sailasuta N, Mizrahi R.

Int J Neuropsychopharmacol. 2018 Apr 1;21(4):311-318. doi: 10.1093/ijnp/pyx094.

29.

Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.

Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Xu C, Sharma S, Kish S, Houle S, Meyer JH.

Lancet Psychiatry. 2018 Apr;5(4):339-347. doi: 10.1016/S2215-0366(18)30048-8. Epub 2018 Feb 26.

PMID:
29496589
30.

Voxel level quantification of [11C]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography.

Rusjan PM, Knezevic D, Boileau I, Tong J, Mizrahi R, Wilson AA, Houle S.

PLoS One. 2018 Feb 14;13(2):e0192410. doi: 10.1371/journal.pone.0192410. eCollection 2018.

31.

A systematic review of the role of the nociceptin receptor system in stress, cognition, and reward: relevance to schizophrenia.

Khan MS, Boileau I, Kolla N, Mizrahi R.

Transl Psychiatry. 2018 Feb 2;8(1):38. doi: 10.1038/s41398-017-0080-8. Review.

32.

Event-Related Potentials in the Clinical High-Risk (CHR) State for Psychosis: A Systematic Review.

Lepock JR, Mizrahi R, Korostil M, Bagby RM, Pang EW, Kiang M.

Clin EEG Neurosci. 2018 Jul;49(4):215-225. doi: 10.1177/1550059418755212. Epub 2018 Jan 31. Review.

PMID:
29382210
33.

A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library.

Adler AS, Bedinger D, Adams MS, Asensio MA, Edgar RC, Leong R, Leong J, Mizrahi RA, Spindler MJ, Bandi SR, Huang H, Tawde P, Brams P, Johnson DS.

MAbs. 2018 Apr;10(3):431-443. doi: 10.1080/19420862.2018.1426422. Epub 2018 Feb 1.

34.

Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Schifani C, Hafizi S, Da Silva T, Watts JJ, Khan MS, Mizrahi R.

Int Rev Psychiatry. 2017 Dec;29(6):555-566. doi: 10.1080/09540261.2017.1396205. Epub 2017 Dec 8. Review.

PMID:
29219634
35.

Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment.

Knezevic D, Verhoeff NPL, Hafizi S, Strafella AP, Graff-Guerrero A, Rajji T, Pollock BG, Houle S, Rusjan PM, Mizrahi R.

J Cereb Blood Flow Metab. 2018 Nov;38(11):1885-1895. doi: 10.1177/0271678X17741395. Epub 2017 Nov 14.

36.

Postsecondary students with psychiatric disabilities identify core services and key ingredients to supporting education goals.

Biebel K, Mizrahi R, Ringeisen H.

Psychiatr Rehabil J. 2018 Dec;41(4):299-301. doi: 10.1037/prj0000280. Epub 2017 Oct 26.

PMID:
29072479
37.

Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.

Tseng HH, Watts JJ, Kiang M, Suridjan I, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Schizophr Bull. 2018 Apr 6;44(3):542-551. doi: 10.1093/schbul/sbx042.

38.

Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics.

Adler AS, Mizrahi RA, Spindler MJ, Adams MS, Asensio MA, Edgar RC, Leong J, Leong R, Johnson DS.

MAbs. 2017 Nov/Dec;9(8):1270-1281. doi: 10.1080/19420862.2017.1371386. Epub 2017 Aug 28.

39.

Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics.

Adler AS, Mizrahi RA, Spindler MJ, Adams MS, Asensio MA, Edgar RC, Leong J, Leong R, Roalfe L, White R, Goldblatt D, Johnson DS.

MAbs. 2017 Nov/Dec;9(8):1282-1296. doi: 10.1080/19420862.2017.1371383. Epub 2017 Aug 28.

40.

The Molecular Basis for Binding of an Electron Transfer Protein to a Metal Oxide Surface.

Fukushima T, Gupta S, Rad B, Cornejo JA, Petzold CJ, Chan LJG, Mizrahi RA, Ralston CY, Ajo-Franklin CM.

J Am Chem Soc. 2017 Sep 13;139(36):12647-12654. doi: 10.1021/jacs.7b06560. Epub 2017 Aug 31.

41.

Towards an Integrated View of Early Molecular Changes Underlying Vulnerability to Social Stress in Psychosis.

Barron H, Hafizi S, Mizrahi R.

Mod Trends Pharmacopsychiatry. 2017;31:96-106. doi: 10.1159/000470810. Epub 2017 Jul 24.

PMID:
28738349
42.

Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system.

Wilson AA, Sadovski O, Nobrega JN, Raymond RJ, Bambico FR, Nashed MG, Garcia A, Bloomfield PM, Houle S, Mizrahi R, Tong J.

Nucl Med Biol. 2017 Oct;53:14-20. doi: 10.1016/j.nucmedbio.2017.05.011. Epub 2017 Jun 1.

PMID:
28719807
43.

Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.

Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, Houle S, Ravindran L, Meyer JH.

JAMA Psychiatry. 2017 Aug 1;74(8):833-840. doi: 10.1001/jamapsychiatry.2017.1567.

44.

West Nile Virus: Seroprevalence in Animals in Palestine and Israel.

Azmi K, Tirosh-Levy S, Manasrah M, Mizrahi R, Nasereddin A, Al-Jawabreh A, Ereqat S, Abdeen Z, Lustig Y, Gelman B, Schvartz G, Steinman A.

Vector Borne Zoonotic Dis. 2017 Aug;17(8):558-566. doi: 10.1089/vbz.2016.2090. Epub 2017 Jun 19.

PMID:
28628400
45.

Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.

Hafizi S, Da Silva T, Gerritsen C, Kiang M, Bagby RM, Prce I, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Neuropsychopharmacology. 2017 Dec;42(13):2474-2481. doi: 10.1038/npp.2017.111. Epub 2017 Jun 12.

46.

Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.

Mabrouk R, Strafella AP, Knezevic D, Ghadery C, Mizrahi R, Gharehgazlou A, Koshimori Y, Houle S, Rusjan P.

PLoS One. 2017 May 17;12(5):e0177785. doi: 10.1371/journal.pone.0177785. eCollection 2017.

47.

Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment.

Knezevic D, Mizrahi R.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):123-131. doi: 10.1016/j.pnpbp.2017.05.007. Epub 2017 May 19. Review.

PMID:
28533150
48.

Mechanisms contributing to cognitive deficits in cannabis users.

Mizrahi R, Watts JJ, Tseng KY.

Neuropharmacology. 2017 Sep 15;124:84-88. doi: 10.1016/j.neuropharm.2017.04.018. Epub 2017 Apr 14. Review.

49.

Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk.

Barron H, Hafizi S, Andreazza AC, Mizrahi R.

Int J Mol Sci. 2017 Mar 17;18(3). pii: E651. doi: 10.3390/ijms18030651. Review.

50.

Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis.

Egerton A, Howes OD, Houle S, McKenzie K, Valmaggia LR, Bagby MR, Tseng HH, Bloomfield MA, Kenk M, Bhattacharyya S, Suridjan I, Chaddock CA, Winton-Brown TT, Allen P, Rusjan P, Remington G, Meyer-Lindenberg A, McGuire PK, Mizrahi R.

Schizophr Bull. 2017 Mar 1;43(2):293-301. doi: 10.1093/schbul/sbw181.

Supplemental Content

Loading ...
Support Center